Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Journal of Cardiovascular Translational Research|August 27, 2025
Platelet Reactivity and Fibrin Clot-Strength as assessed by TEG in Patients with Atrial Fibrillation undergoing Percutaneous Coronary InterventionDiona Gjermeni, Hannah Vetter, Sofia Szabó, et al.
Clinical and Translational Science|March 17, 2022
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR studyMichael Boettcher, Gerd Mikus, Dietmar Trenk, et al.
JACC. Cardiovascular Interventions|January 19, 2016
Randomized Comparison of Different Thienopyridine Loading Strategies in Patients Undergoing Elective Coronary Intervention: The ExcelsiorLOAD TrialWillibald Hochholzer, Michael Amann, Alexander Titov, et al.
Frontiers in Physiology|August 23, 2021
Left Atrial Hypertension, Electrical Conduction Slowing, and Mechanical Dysfunction - The Pathophysiological Triad in Atrial Fibrillation-Associated Atrial CardiomyopathyMartin Eichenlaub, Bjoern Mueller-Edenborn, Jan Minners, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2019
Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trialRalph Hein, Lisa Gross, Dániel Aradi, et al.
ESC Heart Failure|July 24, 2020
The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trialMartin Schulz, Nina Griese-Mammen, Pia M Schumacher, et al.
JACC. Cardiovascular Interventions|January 21, 2017
Randomized Comparison of Oral P2Y12-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor: The ExcelsiorLOAD2 TrialWillibald Hochholzer, Pascal Kleiner, Iris Younas, et al.
Clinical and Translational Science|May 19, 2026
CYP2C19 Polymorphism and Platelet Aggregation-Associated Risks in Atrial Fibrillation Patients Undergoing PCIDiona Gjermeni, Sofia Szabó, Viktoria Anfang, et al.
European Journal of Heart Failure|May 31, 2018
PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot studyUlrich Laufs, Nina Griese-Mammen, Katrin Krueger, et al.
Thrombosis and Haemostasis|August 14, 2018
Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping SubstudyLisa Gross, Dietmar Trenk, Claudius Jacobshagen, et al.
Pageof 12